Jakarta (Indonesia Window) – A total of 14,443,813 Indonesians have received the full doses of the COVID-19 vaccines, according to a report from the National COVID-19 Task Force.
That number includes 175,833 people who were vaccinated on Wednesday (July 7).
Meanwhile, as many as 863,768 people have received the first doses, bringing the total number of first doses of vaccine recipients to 34,039,797 people.
Earlier, the National Agency of Drug and Food Control (locally known as BPOM) issued an Emergency Use Authorization (EUA) for the COVID-19 vaccine made by Moderna, Inc.
The emergency use authorization for the American pharmaceutical company’s vaccine was issued by taking into account the study by the expert team of the National Committee for Assessing the COVID-19 Vaccine and the Indonesian Technical Advisory Group on Immunization.
“BPOM’s task is to support the government to provide assurance and evaluation that vaccines entering Indonesia should meet the aspects of quality, safety, and efficacy,” said BPOM’s Head Penny K Lukito.
She added that Moderna vaccine was the fifth COVID-19 vaccine that attained emergency use authorization from BPOM.
Previously, BPOM issued an emergency use authorization for CoronaVac from Sinovac Life Sciences China; COVID-19 vaccine from Sinovac produced by the Indonesian vaccine manufacturer, Bio Farma; AstraZeneca vaccine from the COVAX Facility; and Sinopharm vaccine from the Beijing Bio-Institute of Biological Products.
Reporting by Indonesia Window